【鱼跃医疗：对明年血糖业务的发展充满信心】金十数据10月28日讯，鱼跃医疗近日接受机构调研时表示，后续公司CGM将会有几款新产品在国内推出，进一步和BGM形成血糖产品矩阵，为客户提供更多选择。海外市场，在未来公司同样有多类型的CGM产品供院内外不同客户选择，同时也在积极推进CGM产品欧洲的注册，目前已经获得CT3注册证，产品品质在不断提升，生产良品率逐步优化，相信也会开始逐步带来销售业绩。从当前在国内外注册证落地工作以及业务拓展情况来看，公司对明年血糖业务的发展充满信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.